{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:26:59Z","timestamp":1767850019819,"version":"3.49.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"9-10","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.vaccine.2003.10.005","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T13:16:36Z","timestamp":1068902196000},"page":"1087-1096","source":"Crossref","is-referenced-by-count":76,"title":["Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers"],"prefix":"10.1016","volume":"22","author":[{"given":"Jo\u00eblle","family":"Bruge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Bouveret-Le Cam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Danve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Rougon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2003.10.005_BIB1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/clinids\/5.1.71","article-title":"Meningococcal disease: still with us","volume":"5","author":"Peltola","year":"1983","journal-title":"Rev. Infect. Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2003.10.005_BIB2","first-page":"575","article-title":"An epidemiological study of purulent meningitis cases admitted to hospital in Dakar, 1970\u20131979","volume":"59","author":"Cadoz","year":"1981","journal-title":"Bull. World Health Organ."},{"issue":"3","key":"10.1016\/j.vaccine.2003.10.005_BIB3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0031-3955(16)33321-1","article-title":"Bacterial meningitis: newer concepts of pathophysiology and neurologic sequelae","volume":"23","author":"Feigin","year":"1976","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.vaccine.2003.10.005_BIB4","unstructured":"Frasch CE. Production and control of Neisseria meningitidis vaccines. New York: Wiley\u2013Liss; 1990. p. 123\u201345."},{"issue":"24","key":"10.1016\/j.vaccine.2003.10.005_BIB5","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.280.24.2094","article-title":"Serogroup Y meningococcal disease in Chicago, 1991\u20131997","volume":"280","author":"Racoosin","year":"1998","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.vaccine.2003.10.005_BIB6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0950268800047713","article-title":"Serotype-specific outbreak of group B meningococcal disease in Iquique","volume":"105","author":"Cruz","year":"1990","journal-title":"Chile. Epidemiol. Infect."},{"issue":"2","key":"10.1016\/j.vaccine.2003.10.005_BIB7","first-page":"57","article-title":"The epidemiology of meningococcal disease in Norway 1975\u201391","volume":"14","author":"Lystad","year":"1991","journal-title":"NIPH Ann."},{"issue":"7","key":"10.1016\/j.vaccine.2003.10.005_BIB8","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JCM.30.7.1734-1738.1992","article-title":"Ongoing group B Neisseria meningitidis epidemic in Sao Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex","volume":"30","author":"Sacchi","year":"1992","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.vaccine.2003.10.005_BIB9","first-page":"21","article-title":"Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989\u20131991","volume":"42","author":"Jackson","year":"1993","journal-title":"Morb. Mortal. Wkly. Rep. CDC Surveill. Summ."},{"issue":"3","key":"10.1016\/j.vaccine.2003.10.005_BIB10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/IAI.65.3.1045-1052.1997","article-title":"Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide\u2013protein conjugate vaccines in juvenile rhesus monkeys","volume":"65","author":"Devi","year":"1997","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.vaccine.2003.10.005_BIB11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00006454-199508000-00001","article-title":"Epidemiology and prevention of meningococcal disease","volume":"14","author":"Riedo","year":"1995","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2003.10.005_BIB12","unstructured":"Zollinger WD. New and improved vaccines against meningococcal disease. New York: Dekker (Marcel); 1997. p. 469\u201388."},{"issue":"5","key":"10.1016\/j.vaccine.2003.10.005_BIB13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic response of man to group B meningococcal polysaccharide vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2003.10.005_BIB14","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.134.4.2651","article-title":"Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis","volume":"134","author":"Jennings","year":"1985","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2003.10.005_BIB15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0264-410X(87)90004-1","article-title":"An integrated molecular and immunological approach towards a meningococcal group B vaccine","volume":"5","author":"Lifely","year":"1987","journal-title":"Vaccine"},{"issue":"8346","key":"10.1016\/j.vaccine.2003.10.005_BIB16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2003.10.005_BIB17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0306-4522(92)90107-D","article-title":"Mapping of the distribution of polysialylated neural cell adhesion molecule throughout the central nervous system of the adult rat: an immunohistochemical study","volume":"49","author":"Bonfanti","year":"1992","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.vaccine.2003.10.005_BIB18","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/eji.1830190935","article-title":"Embryonic neural cell adhesion molecules on human natural killer cells","volume":"19","author":"Husmann","year":"1989","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2003.10.005_BIB19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-199201000-00003","article-title":"Expression of various NCAM isoforms in human embryonic muscles: correlation with myosin heavy chain phenotypes","volume":"51","author":"Figarella-Branger","year":"1992","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/j.vaccine.2003.10.005_BIB20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.onc.1204176","article-title":"A nude mice model of human rhabdomyosarcoma lung metastases for evaluating the role of polysialic acids in the metastatic process","volume":"20","author":"Daniel","year":"2001","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.vaccine.2003.10.005_BIB21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-1759(94)00336-U","article-title":"A monoclonal antibody against meningococcus group B polysaccharides used to immunocapture and quantify polysialylated NCAM in tissues and biological fluids","volume":"181","author":"Dubois","year":"1995","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2003.10.005_BIB22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/(SICI)1096-9861(19990802)410:3<503::AID-CNE11>3.0.CO;2-H","article-title":"Temporal and spacial relationships between PSA-NCAM-expressing, newly generated granule cells, and radial glia-like cells in the adult dentate gyrus","volume":"410","author":"Seki","year":"1999","journal-title":"J. Comp. Neurol."},{"issue":"8775","key":"10.1016\/j.vaccine.2003.10.005_BIB23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2003.10.005_BIB24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"8827","key":"10.1016\/j.vaccine.2003.10.005_BIB25","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2003.10.005_BIB26","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann."},{"issue":"16","key":"10.1016\/j.vaccine.2003.10.005_BIB27","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"J. Am. Med. Assoc."},{"issue":"10","key":"10.1016\/j.vaccine.2003.10.005_BIB28","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0264-410X(96)00001-1","article-title":"Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine","volume":"14","author":"Peeters","year":"1996","journal-title":"Vaccine"},{"issue":"20\/21","key":"10.1016\/j.vaccine.2003.10.005_BIB29","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/S0264-410X(99)00044-4","article-title":"Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins","volume":"17","author":"Cartwright","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2003.10.005_BIB30","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.137.5.1708","article-title":"Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide\u2013tetanus toxoid conjugate vaccine","volume":"137","author":"Jennings","year":"1986","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.vaccine.2003.10.005_BIB31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0882-4010(89)90087-9","article-title":"Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide","volume":"6","author":"Ashton","year":"1989","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.vaccine.2003.10.005_BIB32","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues","volume":"138","author":"Finne","year":"1987","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.vaccine.2003.10.005_BIB33","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1083\/jcb.103.6.2429","article-title":"A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM","volume":"103","author":"Rougon","year":"1986","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.vaccine.2003.10.005_BIB34","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","article-title":"Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.vaccine.2003.10.005_BIB35","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.4049\/jimmunol.142.10.3585","article-title":"Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1","volume":"142","author":"Jennings","year":"1989","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.vaccine.2003.10.005_BIB36","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.vaccine.2003.10.005_BIB37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0882-4010(88)90070-8","article-title":"Experimental meningococcal meningitis in the infant rat","volume":"4","author":"Saukkonen","year":"1988","journal-title":"Microb. Pathog."},{"issue":"4","key":"10.1016\/j.vaccine.2003.10.005_BIB38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0264-410X(89)90194-1","article-title":"Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay","volume":"7","author":"Saukkonen","year":"1989","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2003.10.005_BIB39","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/IAI.69.11.7130-7139.2001","article-title":"Activity and Cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate","volume":"69","author":"Coquillat","year":"2001","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.vaccine.2003.10.005_BIB40","first-page":"503","article-title":"Adverse events temporally associated with meningococcal vaccines","volume":"154","author":"Yergeau","year":"1996","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.vaccine.2003.10.005_BIB41","unstructured":"Bruge J, Moulin J-C, Danve B, Dalla Longa N, Valentin C, Goldman C, et al. Evaluation of the innocuity of a group B meningococcal polysaccharide conjugate in hyperimmunized, pregnant cynomolgus monkeys and their offspring. In: Zollinger WD, Frasch CE, Deal CC, editors. Proceedings of the 10th International Pathogenic Neisseria Conference; 1996. p. 222."},{"issue":"5","key":"10.1016\/j.vaccine.2003.10.005_BIB42","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.4049\/jimmunol.129.5.2172","article-title":"Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants","volume":"129","author":"Mandrell","year":"1982","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.vaccine.2003.10.005_BIB43","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1172\/JCI109383","article-title":"Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man","volume":"63","author":"Zollinger","year":"1979","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.vaccine.2003.10.005_BIB44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0264-410X(91)90318-Z","article-title":"Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins","volume":"9","author":"Lifely","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.10.005_BIB45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1574-6968.1987.tb02293.x","article-title":"Production of colominic acid by Pasteurella haemolytica serotype A 2 organisms","volume":"42","author":"Adlam","year":"1987","journal-title":"FEMS Microbiol. Lett."},{"issue":"2","key":"10.1016\/j.vaccine.2003.10.005_BIB46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/IAI.59.2.732-736.1991","article-title":"Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated)","volume":"59","author":"Devi","year":"1991","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.vaccine.2003.10.005_BIB47","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/IAI.38.3.1203-1207.1982","article-title":"Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay","volume":"38","author":"Leinonen","year":"1982","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.vaccine.2003.10.005_BIB48","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/CDLI.2.5.574-582.1995","article-title":"Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease","volume":"2","author":"Granoff","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.10.005_BIB49","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.vaccine.2003.10.005_BIB50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.vaccine.2003.10.005_BIB51","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/IAI.57.8.2425-2429.1989","article-title":"Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice","volume":"57","author":"Schryvers","year":"1989","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.vaccine.2003.10.005_BIB52","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/IAI.65.3.1053-1060.1997","article-title":"Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide\u2013protein conjugate vaccines","volume":"65","author":"Zollinger","year":"1997","journal-title":"Infect. Immun."},{"issue":"9247","key":"10.1016\/j.vaccine.2003.10.005_BIB53","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(00)03405-X","article-title":"Production of low-avidity antibody by infants after infection with serogroup B meningococci","volume":"356","author":"Pollard","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2003.10.005_BIB54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00006454-200004000-00015","article-title":"Vaccines for prevention of meningococcal disease","volume":"19","author":"Pollard","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"2","key":"10.1016\/j.vaccine.2003.10.005_BIB55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/infdis\/175.2.364","article-title":"Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates","volume":"175","author":"Fusco","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.vaccine.2003.10.005_BIB56","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/172.5.1279","article-title":"Complement-mediated bactericidal activity of human antibodies to poly alpha 2\u21928 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B","volume":"172","author":"Mandrell","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.vaccine.2003.10.005_BIB57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.vaccine.2003.10.005_BIB58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/149.3.387","article-title":"Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis","volume":"149","author":"Skevakis","year":"1984","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.005_BIB59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/00365548909035696","article-title":"Serum opsonins to serogroup B meningococci in meningococcal disease","volume":"21","author":"Halstensen","year":"1989","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.10.005_BIB60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0882-4010(95)90093-4","article-title":"Whole blood model of meningococcal bacteraemia\u2014a method for exploring host\u2013bacterial interactions","volume":"18","author":"Ison","year":"1995","journal-title":"Microb. Pathog."},{"issue":"9","key":"10.1016\/j.vaccine.2003.10.005_BIB61","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1128\/IAI.63.9.3531-3536.1995","article-title":"Comparison among opsonic activity, antimeningococcal immunogloculin G response, and serum bactericidal activity against meningococci in sera from vacinees after immunization with a serogroup B outer membrane vesicle vaccine","volume":"63","author":"Aase","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.10.005_BIB62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-695X.2002.tb00608.x","article-title":"Neisseria meningitidis serogroup B: laboratory correlates of protection","volume":"34","author":"Vermont","year":"2002","journal-title":"FEMS Immunol. Med. Microbiol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03007321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T13:31:42Z","timestamp":1682602302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03007321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":62,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0264410X03007321"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.10.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}